Skip to content

DNIB UNWIND, INC.

Delisted

CIK 1385228fmd_0FKPC4YQRKJ373VBPS6MVV8767Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2011 to Jun 30, 2016, 19 periods

Income Statement · Annual · Millions · USD
Line itemFY2011FY2012FY2013FY2014FY2015
Total revenues11111015
Research and development1113242937
Total operating expenses1620384455
Operating income(15)(19)(27)(34)(39)
Interest expense21102
Interest and investment income000––
Other non-operating income (expense)(2)(1)(1)13
Income tax expense0000–
Net income(17)(19)(28)(33)(37)
Net income to common shareholders(20)(24)(31)(33)(37)
DNIB UNWIND, INC. financial statements · FinancialMD